Corriente Biotechnology Partners

investment firm

About

Corriente Biotechnology Partners was added in 2010.

Details

Operating Status
Active
Investor Type
PE

Investments

Number of Investments
Number of Lead Investments
1
0
Corriente Biotechnology Partners has made 1 investments. Their most recent investment was on Feb 17, 2005, when FibroGen raised $100M.
Date Company Name
Round Money Raised Industry Lead Investor
Feb 17, 2005 FibroGen
Series Unknown $100M Biopharma

Exits

Corriente Biotechnology Partners has had 1 exits. Corriente Biotechnology Partners most notable exits include FibroGen

Date Company Name Exit Type Industry
Nov 21, 2014 FibroGen IPO Biopharma Detail